Earnings History Data for Exact Sciences Corporation (EXAS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Exact Sciences Corporation

EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in the average-risk population. Colorectal cancer, which is the most deadly cancer among non-smokers, is generally curable if detected early. Despite the availability of colorectal cancer screening and diagnostic tests for more than twenty years, the rate of early detection of colorectal cancer remains low, and deaths from colorectal cancer remain high. EXACT Sciences believes its genomics-based technologies would help to enable detection of colorectal cancer so that more people can be effectively treated.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
05-11-2024	AH		EXAS	Exact Sciences Corporation	12,740	-0.21	-0.20	0.00	Exact Sciences GAAP EPS of -$0.21 misses by $0.03, revenue of $709M misses by $7.99M [11/5/2024 4:07 PM]	54.94	-16.58 (-23.18%)	56.15	-15.36 (-21.48%)	40.62 - 79.62	14,595,951	1,650,000	1,073,045
Exact Sciences GAAP EPS of -$0.21 misses by $0.03, revenue of $709M misses by $7.99M [11/5/2024 4:07 PM] Earnings Snapshot: Exact Sciences misses Q3 estimates, cuts expectations for the full year [11/5/2024 4:18 PM] Exact Sciences plummets 28% on revenue guidance cut, Q3 misses [11/5/2024 4:47 PM] Exact Sciences Announces Third-Quarter 2024 Results [2024-11-05 04:05PM] Exact Sciences: Q3 Earnings Snapshot [2024-11-05 04:29PM] Q3 2024 Exact Sciences Corp Earnings Call [2024-11-06 06:55AM] Exact Sciences Corp (EXAS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... [2024-11-06 02:24AM] Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight [2024-11-06 12:02AM] Exact Sciences Stock Falls 29% On Weak Results, Downbeat Outlook [Nov-05-24 08:42PM] Exact Sciences (EXAS) Q3 2024 Earnings Call Transcript [Nov-05-24 07:45PM] Exact Sciences (EXAS) Reports Q3 Loss, Lags Revenue Estimates [Nov-05-24 05:30PM]
31-07-2024	AH		EXAS	Exact Sciences Corporation	8,410	-0.09	-0.37	-0.45	Exact Sciences GAAP EPS of -$0.09 beats by $0.24, revenue of $699.26M beats by $9.16M [7/31/2024 4:12 PM]	57.66	11.98 (26.21%)	54.96	9.28 (20.32%)	40.62 - 96.97	9,325,255	2,910,000	65,564
Exact Sciences GAAP EPS of -$0.09 beats by $0.24, revenue of $699.26M beats by $9.16M [7/31/2024 4:12 PM] Exact Sciences in license agreement with TwinStrand for nucleic acid sequencing [7/31/2024 5:27 PM]
08-05-2024	AH		EXAS	Exact Sciences Corporation	11,500	-0.50	-0.50	-0.42	Exact Sciences GAAP EPS of -$0.60 misses by $0.11, revenue of $637.52M beats by $10.71M [5/8/2024 4:08 PM]	54.49	-4.99 (-8.39%)	54.80	-4.68 (-7.87%)	52.25 - 100.77	9,430,030	2,320,000	467,160
Exact Sciences down 17% on quarterly bottom line miss, maintaining 2024 guidance [5/8/2024 5:28 PM] Exact Sciences GAAP EPS of -$0.60 misses by $0.11, revenue of $637.52M beats by $10.71M [5/8/2024 4:08 PM]
21-02-2024	AH		EXAS	Exact Sciences Corporation	11,030	-0.27	-0.53	-0.72	Exact Sciences GAAP EPS of -$0.27 beats by $0.21, revenue of $647M beats by $7.3M [2/21/2024 4:16 PM]	59.49	-3.80 (-6.00%)	61.51	-1.78 (-2.81%)	58.33 - 100.77	4,160,973	2,160,000	3,483
Exact Sciences GAAP EPS of -$0.27 beats by $0.21, revenue of $647M beats by $7.3M [2/21/2024 4:16 PM]
01-11-2023	AH		EXAS	Exact Sciences Corporation	10,670	N/A	-0.49	-0.84	Exact Sciences GAAP EPS of $0.00 beats by $0.48, revenue of $628M beats by $10.81M [11/1/2023 4:10 PM]	62.46	-1.06 (-1.67%)	63.50	-0.02 (-0.03%)	31.43 - 100.77	2,271,563	1,400,000	2,533
Exact Sciences beats Q3 estimates, raises FY guidance [11/1/2023 4:10 PM]
01-08-2023	AH		EXAS	Exact Sciences Corporation	17,870	-0.45	-0.50	-0.94	Exact Sciences GAAP EPS of -$0.45 beats by $0.06, revenue of $622.1M beats by $20.97M [8/1/2023 4:20 PM]	85.07	-11.37 (-11.79%)	88.00	-8.44 (-8.75%)	29.27 - 100.77	4,211,723	1,530,000	39,866
Exact Sciences GAAP EPS of -$0.45 beats by $0.06, revenue of $622.1M beats by $20.97M [8/1/2023 4:20 PM] Exact Sciences down 4% after hours despite earnings beat, outlook boost [8/1/2023 6:04 PM]
09-05-2023	AH	4:05 PM ET (May 9)	EXAS	Exact Sciences Corporation	12,060	-0.42	-0.79	-1.04	Exact Sciences GAAP EPS of -$0.42 beats by $0.34, revenue of $602.45M beats by $59.27M [5/9/2023 4:12 PM]	78.70	7.70 (10.85%)	79.64	8.64 (12.17%)	29.27 - 80.75	6,587,215	1,750,000	105,145
Exact Sciences GAAP EPS of -$0.42 beats by $0.34, revenue of $602.45M beats by $59.27M [5/9/2023 4:12 PM] Exact Sciences up 6% after hours on raised 2023 revenue guidance [5/9/2023 5:06 PM]
21-02-2023	AH	4:05 PM ET (Feb 21)	EXAS	Exact Sciences Corporation	11,330	-0.72	-0.90	-1.28	Exact Sciences GAAP EPS of -$0.72 beats by $0.11, revenue of $552.9M beats by $27.29M [2/21/2023 4:09 PM]	64.41	3.15 (5.14%)	61.98	0.72 (1.18%)	29.27 - 79.85	3,179,706	1,750,000	9,856
Exact Sciences slips despite Q4 beat after in-line outlook [2/21/2023 4:41 PM] Exact Sciences GAAP EPS of -$0.72 beats by $0.11, revenue of $552.9M beats by $27.29M [2/21/2023 4:09 PM]
03-11-2022	AH	4:05 PM ET (Nov 3)	EXAS	Exact Sciences Corporation	6,160	-0.84	-1.10	-0.97	Exact Sciences GAAP EPS of -$0.84 beats by $0.23, revenue of $523.07M beats by $19.95M [11/3/2022 4:13 PM]	37.41	5.07 (15.68%)	36.32	3.98 (12.31%)	29.27 - 104.50	4,815,261	2,360,000	17,281
Exact Sciences GAAP EPS of -$0.84 beats by $0.23, revenue of $523.07M beats by $19.95M [11/3/2022 4:13 PM] Exact Sciences up 7% in after-hours trading on full-year revenue guidance boost, Q3 beats [11/3/2022 5:46 PM] Exact Sciences Boosts 2022 Outlook After Crushing Third-Quarter Forecasts [Nov-03-22 04:05PM] Exact Sciences Announces Third Quarter 2022 Results [Nov-03-22 04:05PM] Exact Sciences (EXAS) Q3 2022 Earnings Call Transcript [Nov-03-22 10:00PM] Exact Sciences (EXAS) Reports Q3 Loss, Tops Revenue Estimates [Nov-03-22 07:35PM] Exact Sciences Surges After Massively Beating Quarterly Forecasts, Raising Outlook [Nov-03-22 04:20PM]
02-08-2022	AH	4:05 PM ET (Aug 2)	EXAS	Exact Sciences Corporation	7,990	-0.94	-1.07	-1.03	Exact Sciences GAAP EPS of -$0.94 beats by $0.14, revenue of $521.64M beats by $25.5M [8/2/2022 4:14 PM]	47.52	-0.41 (-0.86%)	49.00	1.07 (2.23%)	35.34 - 108.99	2,443,024	1,740,000	8,665
Exact Sciences GAAP EPS of -$0.94 beats by $0.14, revenue of $521.64M beats by $25.5M [8/2/2022 4:14 PM] Exact Sciences posts 2Q beat on screening revenue; trims 2022 guidance [8/2/2022 4:29 PM] MDxHealth acquires Oncotype DX prostate test from Exact Sciences [8/2/2022 6:54 PM] Exact Sciences Announces Second Quarter 2022 Results [Aug-02-22 04:05PM] Exact Sciences and West German Study Group Announce New Study to Validate Detection of Minimal Residual Disease in Early-Stage Breast Cancer Patients [Aug-02-22 04:05PM] Is Cologuard Maker Exact Sciences Underestimating Revenue Guidance? [Aug-02-22 12:49PM] Top 10 Stock Picks of Eli Casdins Casdin Capital [Aug-02-22 09:11AM] Exact Sciences to participate in August investor conference [Aug-01-22 06:00AM] Exact Sciences (EXAS) Q2 2022 Earnings Call Transcript [Aug-02-22 11:30PM] Exact Sciences (EXAS) Reports Q2 Loss, Tops Revenue Estimates [Aug-02-22 06:15PM]
26-04-2022	AH	4:05 PM ET (Apr 26)	EXAS	Exact Sciences	10,618	-1.04	-1.12	0.00	Exact Sciences GAAP EPS of -$1.04 beats by $0.10, revenue of $486.57M beats by $26.67M [4/26/2022 4:12 PM]	62.69	4.06 (6.92%)	60.50	1.87 (3.19%)	56.77 - 140.18	2,965,370	1,870,000	2,657
Exact Sciences GAAP EPS of -$1.04 beats by $0.10, revenue of $486.57M beats by $26.67M [4/26/2022 4:12 PM] Exact Sciences raises guidance after better-than-expected 1Q revenue [4/26/2022 4:30 PM] Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates [Apr-26-22 06:05PM] Exact Sciences (EXAS) Q1 2022 Earnings Call Transcript [Apr-27-22 12:30AM] How Exact Sciences Aims to Keep Its Lead in Cancer Tests [Apr-27-22 09:41AM] Exact Sciences (EXAS) Q1 Earnings Top Estimates, Sales View Up [Apr-27-22 10:25AM] Non-COVID Sales Boost Exact Sciences' Q1 Revenue; Revises FY22 Guidance [Apr-27-22 09:54AM]
22-02-2022	AH	4:05 PM ET (Feb 22)	EXAS	Exact Sciences Corporation	12,990	-1.28	-0.90	-0.09	Exact Sciences GAAP EPS of -$1.28 misses by $0.44, revenue of $473.81M beats by $26.25M [2/22/2022 4:11 PM]	68.99	-4.46 (-6.07%)	73.66	0.21 (0.29%)	66.55 - 140.95	2,823,011	1,640,000	5,698
Exact Sciences GAAP EPS of -$1.28 misses by $0.44, revenue of $473.81M beats by $26.25M [2/22/2022 4:11 PM] Exact Sciences cuts quarterly loss 47%, but still misses on bottom line consensus [2/22/2022 5:13 PM] 3 Stocks to Avoid This Week [Feb-21-22 09:30AM] Exact Sciences Announces Fourth Quarter 2021 Results [Feb-22-22 04:05PM] Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates [Feb-22-22 06:05PM] Cancer-Test Maker Exact Sciences Saw Strong Revenue Growth [Feb-23-22 09:38AM] Exact Sciences (EXAS) Q4 Revenues Top Estimates, Margin Down [Feb-23-22 07:53AM]
02-11-2021	AH	4:05 PM ET (Nov 2)	EXAS	Exact Sciences Corporation	16,640	-0.97	-0.89	-0.36	Exact Sciences EPS misses by $0.12, beats on revenue, updates guidance [11/2/2021 4:09 PM]	94.28	-1.35 (-1.42%)	89.07	-6.56 (-6.86%)	85.82 - 159.54	4,783,206	1,150,000	47,097
Exact Sciences EPS misses by $0.12, beats on revenue, updates guidance [11/2/2021 4:09 PM] Exact Sciences shares fall after Q3 results, FY forecast [11/2/2021 4:26 PM] Exact Sciences downgraded at Raymond James noting a delay in pivotal study [11/3/2021 3:05 PM] Exact Sciences to participate in November investor conferences [Nov-01-21 06:00AM] Exact Sciences announces third quarter 2021 results [Nov-02-21 04:05PM] Exact Sciences (EXAS) Reports Q3 Loss, Tops Revenue Estimates [Nov-02-21 06:25PM] Exact Sciences (EXAS) Q3 2021 Earnings Call Transcript [Nov-03-21 12:31AM] Exact Sciences Shares Drop After Guiding Lower Screening Revenue For FY21 [Nov-03-21 06:24AM] Exact Sciences (EXAS) Q3 Earnings and Revenues Beat Estimates [Nov-03-21 09:37AM]
28-07-2021	AH	4:00 PM ET (Jul 28)	EXAS	Exact Sciences Corporation	19,460	-1.03	-0.72	-0.58	Exact Sciences EPS misses by $0.27, beats on revenue; Screening revenue guidance lowered [7/28/2021 4:11 PM]	112.06	-4.00 (-3.45%)	108.26	-7.80 (-6.72%)	70.75 - 159.54	2,926,755	1,050,000	60,283
Exact Sciences EPS misses by $0.27, beats on revenue; Screening revenue guidance lowered [7/28/2021 4:11 PM] Exact Sciences shares slide after wider Q2 net loss [7/28/2021 4:24 PM] Exact Sciences Announces Second Quarter 2021 Results [Jul-28-21 04:05PM] Why PAVmed Soared by 12% on Wednesday [Jul-28-21 04:42PM] Exact Sciences (EXAS) Reports Q2 Loss, Tops Revenue Estimates [Jul-28-21 05:55PM] Exact Sciences (EXAS) Q2 2021 Earnings Call Transcript [Jul-29-21 02:02AM] Exact Sciences (EXAS) Q2 Loss Wider Than Expected, Revenues Top [Jul-29-21 11:14AM]
04-05-2021	AH	4:05 PM ET (May 4)	EXAS	Exact Sciences Corporation	22,490	-0.18	-1.04	-0.60	Exact Sciences EPS beats by $0.84, beats on revenue [5/4/2021 4:04 PM]	110.50	-5.52 (-4.76%)	117.00	0.98 (0.84%)	70.75 - 159.54	2,298,548	1,110,000	4,237
Exact Sciences EPS beats by $0.84, beats on revenue [5/4/2021 4:04 PM] Exact Sciences Q1 loss narrows as it beats analyst estimates [5/4/2021 5:22 PM] Exact Sciences to participate in May investor conferences [May-03-21 06:00AM] EXACT Sciences Corp. to Host Earnings Call [May-04-21 03:15PM] Exact Sciences Announces First Quarter 2021 Results [May-04-21 04:00PM] Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates [May-04-21 05:25PM] Shares of Cancer Researchers Exact Sciences and Invitae Are Sliding. Heres Why. [May-04-21 06:09PM] Exact Sciences (EXAS) Q1 2021 Earnings Call Transcript [May-05-21 03:31AM] Exact Sciences Beat Expectations in Q1: Why Investors Didn't Jump for Joy [May-05-21 06:01AM] Exact Sciences (EXAS) Q1 Earnings Top Estimates, Margins Down [May-05-21 08:29AM]
16-02-2021	AH	4:05 PM ET (Feb 16)	EXAS	Exact Sciences Corporation	24,750	-0.09	-0.19	-0.37	Exact Sciences EPS misses by $2.59, beats on revenue [2/16/2021 4:08 PM]	141.33	-12.95 (-8.40%)	148.01	-6.27 (-4.06%)	35.25 - 159.54	5,016,457	1,520,088	12,980
Exact Sciences EPS misses by $2.59, beats on revenue [2/16/2021 4:08 PM] Exact Sciences under pressure after earnings miss [2/16/2021 5:52 PM] The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal [Feb-17-21 07:26AM] Exact Sciences (EXAS) Q4 2020 Earnings Call Transcript [Feb-17-21 06:30AM] Dow Jones Futures: Apple, Tesla Test Support As JPMorgan, Caterpillar Break Out; Six Key Earnings Late [Feb-16-21 05:18PM] Exact Sciences to Acquire Ashion Analytics and Enter Research Collaboration with City of Hope's Genomics Institute, TGen [Feb-16-21 04:05PM] Exact Sciences Announces Fourth Quarter 2020 Results [Feb-16-21 04:05PM] EXACT Sciences Corp. to Host Earnings Call [Feb-16-21 02:45PM]
27-10-2020	PM	4:05 PM ET (Oct 29)	EXAS	Exact Sciences Corporation	16,473	-0.36	-0.51	0.00	Exact Sciences EPS misses by $0.93, beats on revenue [10/27/2020 7:13 AM]	131.78	25.21 (23.66%)	114.00	7.43 (6.97%)	35.25 - 141.90	18,174,672	1,128,476	495,876

30-07-2020	AH	4:05 PM ET (Jul 30)	EXAS	Exact Sciences Corporation	14,210	-0.58	-0.62	-0.30	EXACT Sciences EPS beats by $0.43, beats on revenue [7/30/2020 4:22 PM]	93.41	-4.49 (-4.59%)	97.90	0.0 (0.00%)	35.25 - 123.31	1,652,971	1,134,399	71,251

06-05-2020	AH		EXAS	Exact Sciences Corporation	11,580	-0.60	-0.57	-0.66		0.0	0.0 (0.00%)	0.0	0.0 (0.00%)	0.0 - 0.0	0	0	0